Esophagomediastinal and esophagobronchial fistulas associated with invasive aspergillosis.
Kato
S
S
Gastroenterology Division, Yokohama City University, School of Medicine, Kanazawa-ku, Yokohama, Japan. shin800m@yokohama-cu.ac.jp
Inoue
S
S
Inamori
M
M
Miyazawa
N
N
Sato
T
T
Kobayashi
N
N
Mishina
K
K
Sasaki
M
M
Ishigatsubo
Y
Y
Nakajima
A
A
D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D001983:Bronchial Fistula / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D004322:Drainage / Q000379:methods; D004937:Esophageal Fistula / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D004938:Esophageal Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy; D016629:Esophagectomy / Q000379:methods; D004945:Esophagoscopy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D016469:Fungemia / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D008477:Mediastinal Diseases / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D018570:Risk Assessment; D016896:Treatment Outcome
D000935:Antifungal Agents